R
Robert Fagard
Researcher at Katholieke Universiteit Leuven
Publications - 788
Citations - 109235
Robert Fagard is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Blood pressure & Ambulatory blood pressure. The author has an hindex of 114, co-authored 787 publications receiving 104613 citations.
Papers
More filters
Journal ArticleDOI
Association between hypertension and variation in the α- and β-adducin genes in a white population
Ji-Guang Wang,Jan A. Staessen,Cristina Barlassina,Robert Fagard,Tatiana Kuznetsova,Harry A.J. Struijker-Boudier,Laura Zagato,Lorena Citterio,Elisabetta Messaggio,Giuseppe Bianchi +9 more
TL;DR: It is hypothesized that inhibition of the renin-aldosterone system in men and absence of such a compensatory mechanism in women may explain, at least to some extent, the sexual dimorphism of the blood pressure phenotype in relation to the C1797T β-adducin polymorphism.
Journal ArticleDOI
Host and environmental determinants of heart rate and heart rate variability in four European populations.
Katarzyna Stolarz,Jan A. Staessen,Tatiana Kuznetsova,Valérie Tikhonoff,Doina State,Speranta Babeanu,Edoardo Casiglia,Robert Fagard,Kalina Kawecka-Jaszcz,Yuri Nikitin +9 more
TL;DR: In this paper, the authors investigated the association between heart rate and its variability (HRV), and gender, age, posture, breathing frequency, body mass index, systolic blood pressure, family history of hypertension and various lifestyle factors, such as smoking, alcohol and coffee consumption and physical activity.
Journal ArticleDOI
Transforming growth factor-β1 induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts
TL;DR: TGF-β 1 is able to induce the appearance of ACE in cultures of adult rat cardiac ventricular fibroblasts and this induction was accompanied by a profound modification of the fibro Blasts phenotype, which consisted of a change in cell morphology, an enlargement of cell volume and an increase in cell protein content.
Journal ArticleDOI
Cardiovascular risk in white-coat and sustained hypertensive patients.
Hilde Celis,Jan A. Staessen,Lutgarde Thijs,Frank Buntinx,Marc De Buyzere,Elly Den Hond,Robert Fagard,Eoin O'Brien +7 more
TL;DR: In this paper, the authors compared cardiovascular outcome between patients with white-coat and sustained hypertension who had previously participated in the Ambulatory Blood Pressure Monitoring and Treatment of Hypertension (APTH) trial.